Life Sciences Report Collection

The Life Sciences Collection spans markets that are central to the life and wellbeing of the more than 7.5 billion people on our planet. From emerging diagnostics, to brand new therapies and treatment technologies, our expert analysts know where your focus – and investment – should be when it comes to biotechnology, pharmaceuticals and healthcare. As your senior editor, I look forward to introducing you to new opportunities.
Antiemetics: Technologies and Global Markets
The global market for antiemetics reached $4.1 billion in 2017 and should reach $5.9 billion by 2022, at a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2018-2023.
Immunohistochemistry (IHC): Global Markets to 2022
The global immunohistochemistry market totaled $1.6 billion in 2017 and is estimated to reach $2.3 billion by 2022, growing at a compound annual growth rate (CAGR) of 7.8% for the period of 2017-2022.
Cognition and Memory Enhancement Drugs: Technologies and Global M...
The global cognition and memory-enhancing drugs market should reach over $4.2 billion by 2022 from $2.8 billion in 2017 at a compound annual growth rate (CAGR) of 8.7% for the period 2017-2022.
Nutraceuticals: Global Markets to 2023
The global nutraceutical market should reach $336.1 billion by 2023 from $230.9 billion in 2018 at a compound annual growth rate (CAGR) of 7.8%, from 2018 to 2023.
Neuroprotective Agents: Therapeutic Applications and Global Marke...
The global market for neuroprotective agents will grow from $54.4 billion in 2017 to $75.8 billion by 2022 with a compound annual growth rate (CAGR) of 6.8% for the period of 2017-2022.
Microfluidics: Technologies and Global Markets
The global market for microfluidic technologies reached $6.8 billion in 2017 and should reach nearly $13.9 billion by 2022, at a compound annual growth rate (CAGR) of 15.3% for the period of 2017-2022.
Biopesticides: Global Markets to 2022
The global market for synthetic and biopesticides should reach $79.3 billion by 2022 from $61.2 billion in 2017 at a compound annual growth rate (CAGR) of 5.3% during 2017-2022.
Antiulcerant Drugs: Global Markets to 2022
The global antiulcerant drugs market will grow from $33.0 billion in 2017 to $37.4 billion by 2022 with a compound annual growth rate (CAGR) of 2.5% for the period of 2017-2022.
The Chinese Market for DNA Sequencing
The Chinese market for DNA sequencing totaled $1.2 billion in 2017. The market should total $2.9 billion by 2022, growing at a compound annual growth rate (CAGR) of 19.0% during 2017-2022.
Single Blood Drop Analysis: Technologies and Global Market
The global market for single blood drop analysis will grow from $9.2 billion in 2017 to $25.1 billion by 2022 with a compound annual growth rate (CAGR) of 10.6% for the period of 2017-2022.
The Global Influenza Market
The global influenza market was valued at nearly $5.6 billion in 2017 and is expected to reach nearly $6.5 billion by 2022, increasing at a compound annual growth rate (CAGR) of 3.0% from 2017 through 2022.
Cosmetic and Personal Care Stores: Global Markets to 2022
The global cosmetic and personal care stores market totaled $75.3 billion in 2017 and is estimated to reach $100.7 billion by 2022, growing at a compound annual growth rate (CAGR) of 6.0% for the period of 2017-2022.
Food Service Contractors: Global Markets to 2022
The global market for food service contractors will grow from $436.7 billion in 2017 to $602.4 billion by 2022, at a compound annual growth rate (CAGR) of 6.6% for the period of 2017-2022.
Microspheres: Technologies and Global Markets
The global market for microspheres totaled $5.0 billion in 2017 and is estimated to reach $6.9 billion by 2022, growing at a compound annual growth rate (CAGR) of 6.8% for the period of 2017-2022.
Therapies and Diagnostics for Ovarian Cancer: Global Markets to 2...
The global ovarian cancer therapeutic market reached $2.1 billion in 2017. The market should reach $2.9 billion by 2022, growing at a compound annual growth rate (CAGR) of 7.1% during 2017-2022.
Drugs for Urinary Incontinence and Overactive Bladder: Global Mar...
The global drugs for urinary incontinence and overactive bladder market should reach $4.2 billion by 2022 from $3.6 billion in 2017 at a compound annual growth rate (CAGR) of 2.9%, from 2017 to 2022.
Cell Therapy Processing: Global Markets and Technologies
The global market for cell therapy reached $1.3 billion in 2017 and should reach $5.0 billion in 2022 at a compound annual growth rate (CAGR) of 30.9% for the period of 2017-2022.
Fluoroscopy and C-arms: Technologies and Global Markets
The global market for fluoroscopy and C-arms reached $2.2 billion in 2017 and should reach nearly $2.7 billion in 2022 at a compound annual growth rate (CAGR) of 3.8% for the period of 2017-2022.
Muscle Relaxants: Global Markets to 2022
The global muscle relaxants market totaled $18.4 billion in 2017 and is estimated to reach $24.4 billion by 2022, growing at a compound annual growth rate (CAGR) of 5.8% for the period of 2017-2022.
Anti-Epileptic Drugs: Global Markets to 2022
The global anti-epileptic drugs market totaled $8.4 billion in 2017 and is estimated to reach $9.5 billion by 2022, growing at a compound annual growth rate (CAGR) of 2.7% for the period of 2017-2022.
Drugs for Infertility: Global Markets to 2022
The global market for drugs for infertility should reach $4.2 billion by 2022 from $3.4 billion in 2017 at a compound annual growth rate (CAGR) of 4.3%, from 2017 to 2022.
Global Markets and Technologies for Electronic Health Records
The global market for electronic health records totaled $22.0 billion in 2017 and is estimated to reach $39.1 billion by 2022, growing at a compound annual growth rate (CAGR) of 12.2% for the period of 2017-2022.
Cardiovascular Drugs: Global Markets to 2022
The global cardiovascular drugs market should reach $149.4 billion by 2022 from $141.1 billion in 2017 at a compound annual growth rate (CAGR) of 1.2%, from 2017 to 2022.
Small Molecule Therapies for Rheumatoid Arthritis: Global Markets...
The global small molecule therapies for rheumatoid arthritis market totaled $1.7 billion in 2017 and is estimated to reach $2.3 billion by 2022, growing at a compound annual growth rate (CAGR) of 6.6% for the period of 2017-2022.
Bioinspired and Nanoengineered Surfaces: Technologies, Applicatio...
The global market for nanoengineered surfaces will grow from $402.9 million in 2017 to $1.7 billion by 2022 with a compound annual growth rate (CAGR) of 31.7% for the period of 2017-2022.
Nanotechnology in Cancer Treatment: Technologies and Global Markets
This report provides an overview of nanotechnology in cancer treatment and analyzes market trends.
Global Markets and Manufacturing Technologies for Protein Drugs
This report provides an overview of the global markets for protein drugs and drug manufacturing technologies.
Global Biochip Markets: Microarrays and Lab-on-a-Chip
This report provides an overview of the global biochip markets.
Global Microbiome Sequencing Market
This report provides an overview of the global market for microbiome sequencing.